Misfolding and abnormal aggregation of α-synuclein are important causes of degeneration of dopaminergic neurons, and in PD, the up-regulated O-GlcNAc level of α-synuclein can effectively inhibit its misfolding and aggregation, thereby preventing the harm caused by protein degeneration to neurons. Here, SNCA is linked to Parkinson disease.